Pre Analytical Errors 1
Pre Analytical Errors 1
Pre Analytical Errors 1
Laboratory Medicine
Mr.Sreekanth P G
Medical Biochemist
Pre-Analytic Issues in
Laboratory Medicine
Mr.Sreekanth P G
Laboratory Testing
Impacts Nearly Everyone
Infant
Child
Teen
Adult
Senior
ERRORS
May occur
Can not be eliminated but can be
minimised
QUALITY ASSUARANCE
The practice which encompasses all
eneavors, procedures, formats and
activities directed towards ensuring that
aspecified quality product achieved and
maintained
Quality System
Quality Assurance
Quality Control
Phases of Testing
Pre-Analytical
Test Ordering, Specimen Collection, Specimen
Handling
Analytical
Test Performance, Quality Control, Result
Review
Post-Analytical
Result handling, Result Communication, Result
Interpretation
ANALYTICAL ERRORS
Analytical
Instrument not calibrated Measurement
correctly
Specimens mix up
Incorrect volume of specimen
Interfering substances present
Instrument precision problem
Test reporting
Wrong patient ID
Report not legible
Report delayed
Transcription error
Patient Identification
It is important to identify a patient properly so
that
blood is collected from the correct person.
.1% - 1% of specimens are from the wrong
patient.
Two patient identifiers should be used.
Hospital inpatients should be wearing an
identification band
Test forms should be compared to the inpatient's
wrist bracelet or verbally confirmed with an
outpatient.
and
patient ID using two identifiers
Draw and label specimens at the bedside, one patient
at a time
Affix proper specimen labels to the collection tubes
immediately after specimen collection Do not draw extra
unlabeled tubes
The person who collects the specimen should label the
specimen
Avoid secondary labeling where the specimen is
labeled by hand and then printed labels are attached
later.
PHLEBOTOMY
In the 20th century
Specimen Collection
Postural Effects
Collection Tubes and Additives
Affect of Tourniquet Time
Collection from IVs and Catheters
Volume effects
Avoiding Clots
Avoiding Hemolysis
Postural Effects
Change in posture from supine to erect or
Postural Effects
Albumin levels are higher among healthy outpatients as
compared to supine healthy hospitalized subjects
Glucose (and other small molecules) move freely
between the
interstitial space and the circulation and are least affected
by posture during blood specimen collection.
While the free fraction of a metabolite, drug, hormone,
or metal ion is not subject to postural variation, the
fraction bound to proteins is affected by posture.
Thus, bilirubin bound to albumin and calcium bound to
albumin are affected by postural changes.
A change from upright to supine can reduce (after 5
minutes) cholesterol level by 10% and triglyceride by
12%.
Site Preparation:
Before performing the venipuncture, the alcohol should
be allowed to air dry. This will help to ensure that the specimen is not
contaminated with alcohol, as this can lead to hemolysis. Hemolysis
can result in the spurious elevation of such analytes as potassium,
lactate dehydrogenase (LD), iron and magnesium in the chemistry
lab.
Proper Venipuncture Technique:
During phlebotomy, avoid probing
to find the vein and achieve blood flow. Excessive probing and/or
fishing to find a vein can result in a poor quality sample, including
hemolysis.
Order of Draw: Following the correct order of draw during
venipuncture will help to ensure accurate test results.)
Heparin
Used to collect whole blood or plasma
Binds to anti-thrombin III to inhibit Xa,
IXa, and thrombin
Nominal concentration of 12 30 U/mL
Heparin binds calcium so ionized
calcium must be collected using Calcium
Titrated or Electrolyte Balanced heparin
EDTA
K2EDTA is used to collect whole blood
for hematology studies and plasma for
analytes with heparin interference
Acts by binding calcium
Nominal concentration of 1.5 mg/mL
Recent move to K2EDTA from K3EDTA
for hematology to reduce affect on RBC
parameters
EDTA Effects
EDTA is hyperosmolar causing cell
shrinkage but the
low pH of EDTA counterbalances this effect
by causing K to flow into cells.
EDTA may cause platelet clumping and
platelet satellitism
Sodium citrate tubes are sometimes
collected to obtain more accurate platelet
counts.
sample) a low platelet count is obtained with some samples. This due
to platelet clumps showing many platelets as ONE or gating these
platelets out because their clumped size is close to that of a micro
RBC.
Platelet satelitism is another suspect.
When these patients samples are repeated using a CITRATE sample
instead,
TWO different categories emerge: a- A normal platelet count is
obtained with a so-called "EDTA artefact patients".
The other blood indices are inaccurate - ONLY the platelet count is
correct. The CBC should be reported with the CITRATE platelets and
EDTA WBC & RBC data.
b- A low platelet count is obtained (almost identical to EDTA
samples). This is a genuine LOW platelet count that can be
confirmed with both slide viewing and manual counting of platelets.
So, before reporting that platelet count as LOW: Check the sample
for micro clots. Make a blood film and check if they are really low.
Check it with a CITRATE sample (to get a count if it is normal). DO
NOT REPORT CBC OF A CITRATED SAMPLE - only the Platelet
count!
Citrate
Citrate is most often used for collection of
coagulation tests
Acts by binding calcium
Nominal concentration of 3.2% (mol/L)
Recent move to 3.2% from 3.8% to get
more consistent results for Prothrombin
Time, particularly for more sensitive reagents
Tubes must be properly filled to within +/10 percent of assigned collection volume
NaF + K Oxalate
NaF + K Oxalate is used to poison glycolytic
Clot Activator
In vitro activation of clotting system to
enhance clot formation
Tubes contain a silica clot activator attached to
the wall with a silicone surfactant
Requires inversion of tube for optimal
function
Requires 15 to 30 minutes (instead of 1 hour)
to complete clot formation.
Duration of Tourniquet
Application
Application of the tourniquet for >1 minute can result in
Order of Draw
Syringe Collection
Visual hemolysis was found in 19% of specimens drawn by
syringe,
compared to 3% when drawn by an evacuated tube system.
Also, 11% of syringe-collected EDTA samples exhibited clots
Following can reduce the incidence of hemolysis:
Pump the plunger 2-3 times prior to collection to loosen the
plunger.
Use a 3-10 mL syringe
Ensure that the speed of aspiration does not exceed 1mL of
air space during collection. Excessive aspiration forces cause
hemolysis.
Transfer the blood to the tubes immediately.
Fill tube by vacuum only. NEVER push down on the plunger;
this increases the force of the blood flow, creating a high
degree of red blood cell trauma.
Use a blood transfer device to transfer syringe-collected blood
into a tube. It will enhance safety and improve specimen quality.
Collection Volume
Overfilled tubes
Under filled coagulation tube
Under filled hematology tube
Under filling occurs because:
Tube was removed too quickly
Tube slips back from vacutainer needle
Air drawn in from butterfly or connector
tubing
Avoiding Clots
Use a sufficient amount of the correct
anticoagulant
Mix specimen thoroughly after
collection
Transfer immediately from syringe to
tube
Do not overfill tubes
Avoiding Hemolysis
specimen
Delay in analysis can cause high pO2 to fall or low pO2 to
rise
Analyze within 30 minutes or place on ice and analyze within
1 hour.
Ca2+ binding by heparin can be minimized by using either of
the following:
(1) A final concentration of sodium or lithium heparinate of
15 IU/ml blood or less
(2) Calcium titrated heparin with a final concentration of less
than 50 IU/ml blood.
Heparin Dilution effect can be avoided by use of dry heparin
Roll specimen to mix heparin and reduce clots
Specimen Transport
Specimens should be delivered to the
laboratory promptly after collection
Specimens should not be placed on ice
unless specified by the laboratory
Pneumatic tube transport does not affect
analytical results
vacutainer
Forcing blood from syringe into tube when it has
started to
clot
Shaking of tube instead of gentle agitation or inversion
Inadequate packing in pneumatic tube container during
transport to the laboratory to prevent shaking
Prolonged contact of plasma or serum with cells
Chilling (or freezing) of whole blood specimens
For skin puncture specimens, squeezing tissues too
hard
during collection
Fibrin Interference
Residual fibrin, long recognized as a possible interferent in
the clinical laboratory, may be present as a result of
improper specimen handling during and after collection.
It can be present in primary tube samples either as a visible
clot, which may physically occlude the instrument
sample probe or,as an invisible microfiber or as strands.
Fibrin strands,though invisible, may directly affect some
assays, especially immunoassays.
Fibrin interference is usually not reproducible and
disappears with time as the fibrin settles out of the
sample.
Care taken during the preanalytical phase can help to
reduce the presence of fibrin strands in the processed
specimen.
Blood Tubes
Figure 2-3
Venipuncture
1
Bloo
d
Gel
Seru
m
Gel
Clotte
d
blood
NO
!
Yes
Figure 2-6
Microcollection tubes
Table 2-3
Differences in Composition between Plasma and Serum
Value Ratio
Analyte
Calcium
Chloride
Lactate dehydrogenase
Total protein
No difference between
serum and plasma values
Bilirubin
Cholesterol
Creatinine
Albumin
Alkaline phosphatase
Aspartate aminotransferase
Bicarbonate
Creatin kinase
Glucose
Phosphate
Potassium
Sodium
Urea
Uric acid
Percent (%)
0.9
0.2
2.7
4.0
1.3
1.6
0.9
1.8
2.1
5.1
7.0
8.4
0.1
0.6
2.0
Table 2-4
Difference
in
composition
between
Value Ratios
Analyte
Percent (%)
capillary
andthan
venous
serum
Capillary
value greater
Glucose
1.4
venous value
Potassium
No difference between
capillary and venous values
Phosphate
Urea
Bilirubin
Calcium
Chloride
Sodium
Total protein
0.9
5.0
4.6
1.8
2.3
3.3
Common sense in
Laboratory Practice
Mr.Sreekanth P G
Lecturer In Medical Biochemistry
University of Calicut
Glucose
320 mg/dl vs 640 mg/dl
Tendancy to normalise
Standards /calibrators
Possible upper value?
Linearity
instrument
reagent
Dilutions solve the issue
undiluted
dilution
1/10 dilution
500
500
250
300
50 60
Calcium
Tourniquet
Contaminated glassware
Use acid washed tubes /disposable plastic
tubes
Urine M/E
Pus cells 6 10/HPF
15-20/HPF
Volume
Centrifugation
Blood Glucose
1100 mg/dl
CPK
6000 U/L
RA Factor
2000 IU/ml
Bilirubin
32 mg/dl
Creatinine
25 mg/dl
ASO
2000 IU/ml
K
Quality Assurance in
Healthcare
The Right result, at the
Right time,
on the
Right specimen, from the
Right patient, with result interpretation
based on
Correct Reference data, and at the
Right price